Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 421

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Serum irisin levels in new-onset type 2 diabetes

Open access
Choi, Yeon-Kyung, Kim, Mi-Kyung, Bae, Kwi Hyun, Seo, Hyun-Ae, Jeong, Ji-Yun, Lee, Won-Kee, Kim, Jung-Guk, Lee, In-Kyu, Park, Keun-Gyu · 2013 · Diabetes Research and Clinical Practice

Abstract

AIMS Irisin has been identified as a novel myokine that drives brown-fat-like conversion of white adipose tissue. In this cross-sectional study, we investigated whether serum irisin levels are decreased in patients with type 2 diabetes (T2D) compared with control subjects with normal glucose tolerance (NGT), and assessed the association between serum irisin levels and various metabolic parameters. METHODS The study population was selected from a population-based study and included 104 subjects with NGT and 104 subjects with new-onset T2D. Serum irisin and adiponectin levels and metabolic parameters were measured. Multivariate logistic regression analysis was performed to assess the association between irisin levels and newly diagnosed T2D. RESULTS Serum irisin levels were significantly decreased in the new-onset T2D group compared with the NGT control group (p=0.003). In a multivariable model adjusted for various metabolic parameters, increased irisin levels were associated with reduced odds (OR 0.64, 95% CI 0.47-0.88, p=0.006) of prevalent newly diagnosed T2D. Furthermore, multiple regression analysis showed that 2 h plasma glucose was an independent variable influencing serum irisin levels (p=0.004). CONCLUSION In the present study, we found that serum irisin levels were decreased in T2D patients and inversely associated with newly diagnosed T2D, suggesting that irisin may play a crucial role in glucose intolerance and T2D.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.diabres.2013.01.007

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 32 references

Cited by

See all 421

Metadata

Authors
Choi, Y.-K., Kim, M.-K., Bae, K. H., Seo, H.-A., Jeong, J.-Y., Lee, W.-K., Kim, J.-G., Lee, I.-K., & Park, K.-G.
Venue
Diabetes Research and Clinical Practice
Publisher
Elsevier BV
Published
2013-04
Volume
100
Issue
1
Pages
96-101
ISSN
0168-8227 (ISSN-L)
OpenAlex
W2129882955
Cited by
421
References
32
FWCI
35.67
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum irisin levels in new-onset type 2 diabetes. https://app.cochat.ai/papers/10.1016/j.diabres.2013.01.007
The paper
Choi, Y.-K., Kim, M.-K., Bae, K. H., Seo, H.-A., Jeong, J.-Y., Lee, W.-K., Kim, J.-G., Lee, I.-K., & Park, K.-G. (2013). Serum irisin levels in new-onset type 2 diabetes. Diabetes Research and Clinical Practice. https://doi.org/10.1016/j.diabres.2013.01.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.